Randomized patients underwent one of the following priming strategies : transdermal testosterone ( @ g/kg/d ) , transdermal estradiol ( @ g/d ) , or combined estrogens and oral contraceptive pills ( @ g of ethinyl estradiol plus @ g of desogestrel administered during the luteal phase of two consecutive cycles ) and @ mg/d of estradiol valerate during the follicular phase between them .